Optimizing Aligner Wear Time and Change Frequency

February 13, 2020 updated by: Harvard School of Dental Medicine

Optimizing Aligner Wear Time and Change Frequency: A Single-Blind, Randomized Control Trial

This study aims to help improve individualization and optimization of clear aligner therapy through the use of new technologies in orthodontics. The study will compare 12-hour and 22-hour tray wear time and evaluate the adjunctive use of Vpro+. The study clinicians will use Dental Monitoring to monitor study participants throughout the trial and will use the Dental Monitoring system to instruct patients to continue or stay on their clear aligners. The outcome of the study will be the time it takes to complete 10 trays.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

85

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Male and female subjects ages 18-65 years of age with complete adult dentition, with Class I malocclusion or mild Class II/III malocclusions who are currently in treatment.
  • Subjects who do not have systemic diseases that affect orthodontic tooth movement such as patients who are using hormone replacement medications, bone diseases such as osteoporosis or hyper/hypo-thyroidism
  • Periodontal probing depths (PD) < 4mm, gingival index (GI) ≤1, and plaque index (PI) ≤1
  • Patients currently in orthodontic treatment with Invisalign who are currently changing their trays every 7 - 10 days
  • Participant must have a smartphone that is capable of downloading and storing the Dental Monitoring application
  • Participants must be able to master the use of the Dental Monitoring Application

Exclusion Criteria:

Inclusion:

  • Male and female subjects ages 18-65 years of age with complete adult dentition, with Class I malocclusion or mild Class II/III malocclusions who are currently in treatment.
  • Subjects who do not have systemic diseases that affect orthodontic tooth movement such as patients who are using hormone replacement medications, bone diseases such as osteoporosis or hyper/hypo-thyroidism
  • Periodontal probing depths (PD) < 4mm, gingival index (GI) ≤1, and plaque index (PI) ≤1
  • Patients currently in orthodontic treatment with Invisalign who are currently changing their trays every 7 - 10 days
  • Participant must have a smartphone that is capable of downloading and storing the Dental Monitoring application
  • Participants must be able to master the use of the Dental Monitoring Application

Exclusion:

  • Subjects who have within the last 6 mo taken any antibiotic medications or have had any periodontal treatments
  • Subjects who have taken/are taking medications that affect bone remodeling: anti-resorptive medications, medications that may affect hormone levels, thyroid replacement medications, corticosteroids, and daily nonsteroidal anti-inflammatory medications
  • Subjects who have had chemotherapy or radiation therapy in the last 6 mo
  • Subjects who present with severe class II/III malocclusions
  • Subjects who present with class I malocclusions but have severe crowding (> 7 mm) that requires extraction, >4 mm positive overjet and > 2 mm negative overjet, extreme deep bite ( > 90%), severe open bite (>2 mm)
  • Women who are pregnant
  • Patients that smoke
  • Patients with active caries
  • Patients that require interproximal reduction or attachments in the remaining prescription
  • Patients who have temporary anchorage devices in place
  • Patients who have vertigo or issues with their temporomandibular joint
  • Patients with less than 3 mo. remaining in aligner treatment
  • Patients who have documented bruxism

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Group 1
22-hour tray wear time, DM assisted aligner change frequency
Active Comparator: Group 2
22-hour tray wear time, VPro+ (active), DM assisted aligner change frequency

The current standard of care for clear aligner use as suggested by Invisalign is unclear as to how frequently aligners should be changed. We suspect that the frequency for aligner change as determined by the orthodontist using Dental Monitoring will be variable for every participant.

Vpro+ is an adjunctive therapeutic tool for clear aligner treatment. It is proposed to deliver high frequency vibrations to reduce treatment time and pain associated with clear aligners.

Align Technology suggests 22-hour wear time for clear aligner therapy. Participants in two arms of the study will be asked to wear the trays for about half the recommended wear time to assess whether night-time aligner wear will be sufficient for successful treatment.

Sham Comparator: Group 3
22-hour tray wear time, VPro+ (inactive), DM assisted aligner change frequency

The current standard of care for clear aligner use as suggested by Invisalign is unclear as to how frequently aligners should be changed. We suspect that the frequency for aligner change as determined by the orthodontist using Dental Monitoring will be variable for every participant.

Vpro+ is an adjunctive therapeutic tool for clear aligner treatment. It is proposed to deliver high frequency vibrations to reduce treatment time and pain associated with clear aligners.

Align Technology suggests 22-hour wear time for clear aligner therapy. Participants in two arms of the study will be asked to wear the trays for about half the recommended wear time to assess whether night-time aligner wear will be sufficient for successful treatment.

Active Comparator: Group 4
12-hour tray wear time, VPro+ (active), DM assisted aligner change frequency

The current standard of care for clear aligner use as suggested by Invisalign is unclear as to how frequently aligners should be changed. We suspect that the frequency for aligner change as determined by the orthodontist using Dental Monitoring will be variable for every participant.

Vpro+ is an adjunctive therapeutic tool for clear aligner treatment. It is proposed to deliver high frequency vibrations to reduce treatment time and pain associated with clear aligners.

Align Technology suggests 22-hour wear time for clear aligner therapy. Participants in two arms of the study will be asked to wear the trays for about half the recommended wear time to assess whether night-time aligner wear will be sufficient for successful treatment.

Sham Comparator: Group 5
12-hour tray wear time, VPro+ (inactive), DM assisted aligner change frequency

The current standard of care for clear aligner use as suggested by Invisalign is unclear as to how frequently aligners should be changed. We suspect that the frequency for aligner change as determined by the orthodontist using Dental Monitoring will be variable for every participant.

Vpro+ is an adjunctive therapeutic tool for clear aligner treatment. It is proposed to deliver high frequency vibrations to reduce treatment time and pain associated with clear aligners.

Align Technology suggests 22-hour wear time for clear aligner therapy. Participants in two arms of the study will be asked to wear the trays for about half the recommended wear time to assess whether night-time aligner wear will be sufficient for successful treatment.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Time to complete 10 trays to determine the average aligner change frequency measured at the completion of the study
Time Frame: 70-140 days
70-140 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

March 1, 2020

Primary Completion (Anticipated)

November 1, 2020

Study Completion (Anticipated)

March 1, 2021

Study Registration Dates

First Submitted

February 5, 2020

First Submitted That Met QC Criteria

February 5, 2020

First Posted (Actual)

February 7, 2020

Study Record Updates

Last Update Posted (Actual)

February 17, 2020

Last Update Submitted That Met QC Criteria

February 13, 2020

Last Verified

February 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • IRB19-0644

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Adjunctive Usage of Vibrational Therapy

Subscribe